Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated:  10/17/2017
NorthShore University HealthSystem-Glenbrook Hospital
1722
mi
from 91732
Glenview, IL
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated: 10/17/2017
NorthShore University HealthSystem-Glenbrook Hospital
1722
mi
from 91732
Glenview, IL
Click here to add this to my saved trials
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated:  10/17/2017
Sportsmed Sa
8189
mi
from 91732
Stepney,
Massachusetts General Hospital Evaluation of DePuy ASR Hip System
Clinical Follow-up of ASR Patients Post-Recall
Status: Enrolling
Updated: 10/17/2017
Sportsmed Sa
8189
mi
from 91732
Stepney,
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
333
mi
from 91732
Peoria, AZ
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
333
mi
from 91732
Peoria, AZ
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
97
mi
from 91732
Palm Desert, CA
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
97
mi
from 91732
Palm Desert, CA
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
2312
mi
from 91732
Boca Raton, FL
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
2312
mi
from 91732
Boca Raton, FL
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
2144
mi
from 91732
Brandon, FL
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
2144
mi
from 91732
Brandon, FL
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
2127
mi
from 91732
Jacksonville, FL
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
2127
mi
from 91732
Jacksonville, FL
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
mi
from 91732
Miami Lakes, FL
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
mi
from 91732
Miami Lakes, FL
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
2321
mi
from 91732
Miami, FL
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
2321
mi
from 91732
Miami, FL
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
2148
mi
from 91732
Sarasota, FL
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
2148
mi
from 91732
Sarasota, FL
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
1401
mi
from 91732
Shreveport, LA
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
1401
mi
from 91732
Shreveport, LA
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
1894
mi
from 91732
Lansing, MI
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
1894
mi
from 91732
Lansing, MI
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
2202
mi
from 91732
Durham, NC
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
2202
mi
from 91732
Durham, NC
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
2025
mi
from 91732
Middleburg Heights, OH
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
2025
mi
from 91732
Middleburg Heights, OH
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
2200
mi
from 91732
Duncansville, PA
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
2200
mi
from 91732
Duncansville, PA
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
922
mi
from 91732
Amarillo, TX
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
922
mi
from 91732
Amarillo, TX
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
1213
mi
from 91732
Austin, TX
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
1213
mi
from 91732
Austin, TX
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
Clinical Research Facility
1235
mi
from 91732
Mesquite, TX
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
Clinical Research Facility
1235
mi
from 91732
Mesquite, TX
Click here to add this to my saved trials
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated:  10/23/2017
6666
mi
from 91732
Plovdiv,
A Study to Compare FKB327 Efficacy and Safety With Humira® in Rheumatoid Arthritis Patients
A Randomised, Blinded, Active-Controlled Study to Compare FKB327 Efficacy and Safety With the Comparator Humira® in Rheumatoid Arthritis Patients Inadequately Controlled on Methotrexate
Status: Enrolling
Updated: 10/23/2017
6666
mi
from 91732
Plovdiv,
Click here to add this to my saved trials
Weight-Bearing Tomosynthesis In Evaluation of Foot/AnkIe
Weight-Bearing Tomosynthesis In Evaluation of Foot/AnkIe
Status: Enrolling
Updated:  10/24/2017
Univ of Washington
961
mi
from 91732
Seattle, WA
Weight-Bearing Tomosynthesis In Evaluation of Foot/AnkIe
Weight-Bearing Tomosynthesis In Evaluation of Foot/AnkIe
Status: Enrolling
Updated: 10/24/2017
Univ of Washington
961
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Evaluation of Amniotic Fluid Product in Knee Osteoarthritis
Protocol for the Clinical Evaluation Amniotic Fluid (AF) Product in Knee Osteoarthritis
Status: Enrolling
Updated:  10/25/2017
Central Research Associates, Inc
1785
mi
from 91732
Birmingham, AL
Evaluation of Amniotic Fluid Product in Knee Osteoarthritis
Protocol for the Clinical Evaluation Amniotic Fluid (AF) Product in Knee Osteoarthritis
Status: Enrolling
Updated: 10/25/2017
Central Research Associates, Inc
1785
mi
from 91732
Birmingham, AL
Click here to add this to my saved trials
Evaluation of Amniotic Fluid Product in Knee Osteoarthritis
Protocol for the Clinical Evaluation Amniotic Fluid (AF) Product in Knee Osteoarthritis
Status: Enrolling
Updated:  10/25/2017
Weil Foot, Ankle and Orthopedic Institute
1718
mi
from 91732
Des Plaines, IL
Evaluation of Amniotic Fluid Product in Knee Osteoarthritis
Protocol for the Clinical Evaluation Amniotic Fluid (AF) Product in Knee Osteoarthritis
Status: Enrolling
Updated: 10/25/2017
Weil Foot, Ankle and Orthopedic Institute
1718
mi
from 91732
Des Plaines, IL
Click here to add this to my saved trials
Sleep and Immunity in Rheumatoid Arthritis : Remicade Substudy
Sleep & Immune Mechanisms in Rheumatoid Arthritis: Remicade Substudy
Status: Enrolling
Updated:  10/26/2017
University of California, Los Angeles, General Clinical Research Center
24
mi
from 91732
Los Angeles, CA
Sleep and Immunity in Rheumatoid Arthritis : Remicade Substudy
Sleep & Immune Mechanisms in Rheumatoid Arthritis: Remicade Substudy
Status: Enrolling
Updated: 10/26/2017
University of California, Los Angeles, General Clinical Research Center
24
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Does Fluid Replacement From Preoperative NPO Status Improve Postoperative Recovery
Does Fluid Replacement From Preoperative NPO Status Improve Postoperative Recovery and Reduce Complications in Arthroplasty Patients?
Status: Enrolling
Updated:  10/26/2017
WVU Medicine Department of Orthopaedics
2122
mi
from 91732
Morgantown, WV
Does Fluid Replacement From Preoperative NPO Status Improve Postoperative Recovery
Does Fluid Replacement From Preoperative NPO Status Improve Postoperative Recovery and Reduce Complications in Arthroplasty Patients?
Status: Enrolling
Updated: 10/26/2017
WVU Medicine Department of Orthopaedics
2122
mi
from 91732
Morgantown, WV
Click here to add this to my saved trials
High Intensity Interval Training in Osteoarthritis, Effects on Metabolomics
Feasibility and Initial Effects of High Intensity Interval Training on Knee Osteoarthritis: an Exploratory Evaluation on Metabolomics
Status: Enrolling
Updated:  10/27/2017
Applied Physiology Laboratory
1991
mi
from 91732
Chapel Hill, NC
High Intensity Interval Training in Osteoarthritis, Effects on Metabolomics
Feasibility and Initial Effects of High Intensity Interval Training on Knee Osteoarthritis: an Exploratory Evaluation on Metabolomics
Status: Enrolling
Updated: 10/27/2017
Applied Physiology Laboratory
1991
mi
from 91732
Chapel Hill, NC
Click here to add this to my saved trials
Strength Training for ARthritis Trial
Strength Training for ARthritis Trial
Status: Enrolling
Updated:  11/2/2017
Wake Forest University
2125
mi
from 91732
Winston-Salem, NC
Strength Training for ARthritis Trial
Strength Training for ARthritis Trial
Status: Enrolling
Updated: 11/2/2017
Wake Forest University
2125
mi
from 91732
Winston-Salem, NC
Click here to add this to my saved trials
Intensive Diet and Exercise for Improving Knee Osteoarthritis in Obese and Overweight Older Adults
Intensive Diet and Exercise for Arthritis
Status: Enrolling
Updated:  11/2/2017
Wake Forest University/Wake Forest University Forest School of Medicine
2124
mi
from 91732
Winston-Salem, NC
Intensive Diet and Exercise for Improving Knee Osteoarthritis in Obese and Overweight Older Adults
Intensive Diet and Exercise for Arthritis
Status: Enrolling
Updated: 11/2/2017
Wake Forest University/Wake Forest University Forest School of Medicine
2124
mi
from 91732
Winston-Salem, NC
Click here to add this to my saved trials
Real-world Clinical Efficacy of Abatacept in the T3 Data Registry
Abatacept in T3: A Characterization of Abatacept's Efficacy and Outcomes From a Real-Word Clinical Practice Information Hub on Novel Patient Sub-Groups
Status: Enrolling
Updated:  11/2/2017
Arthritis Northwest
938
mi
from 91732
Spokane, WA
Real-world Clinical Efficacy of Abatacept in the T3 Data Registry
Abatacept in T3: A Characterization of Abatacept's Efficacy and Outcomes From a Real-Word Clinical Practice Information Hub on Novel Patient Sub-Groups
Status: Enrolling
Updated: 11/2/2017
Arthritis Northwest
938
mi
from 91732
Spokane, WA
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
14
mi
from 91732
Glendale, AZ
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
14
mi
from 91732
Glendale, AZ
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
333
mi
from 91732
Peoria, AZ
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
333
mi
from 91732
Peoria, AZ
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
343
mi
from 91732
Phoenix, AZ
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
343
mi
from 91732
Phoenix, AZ
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
427
mi
from 91732
Tucson, AZ
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
427
mi
from 91732
Tucson, AZ
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
207
mi
from 91732
Fresno, CA
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
207
mi
from 91732
Fresno, CA
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
99
mi
from 91732
La Jolla, CA
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
99
mi
from 91732
La Jolla, CA
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
97
mi
from 91732
Palm Desert, CA
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
97
mi
from 91732
Palm Desert, CA
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
144
mi
from 91732
Santa Maria, CA
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
144
mi
from 91732
Santa Maria, CA
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
20
mi
from 91732
Upland, CA
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
20
mi
from 91732
Upland, CA
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
813
mi
from 91732
Boulder, CO
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
813
mi
from 91732
Boulder, CO
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
817
mi
from 91732
Denver, CO
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
817
mi
from 91732
Denver, CO
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
2458
mi
from 91732
Danbury, CT
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
2458
mi
from 91732
Danbury, CT
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
2472
mi
from 91732
Trumbull, CT
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
2472
mi
from 91732
Trumbull, CT
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
2384
mi
from 91732
Lewes, DE
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
2384
mi
from 91732
Lewes, DE
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
2309
mi
from 91732
Boynton Beach, FL
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
2309
mi
from 91732
Boynton Beach, FL
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
2220
mi
from 91732
Naples, FL
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
2220
mi
from 91732
Naples, FL
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
2114
mi
from 91732
New Port Richey, FL
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
2114
mi
from 91732
New Port Richey, FL
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
2182
mi
from 91732
Orlando, FL
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
2182
mi
from 91732
Orlando, FL
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
2117
mi
from 91732
Palm Harbor, FL
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
2117
mi
from 91732
Palm Harbor, FL
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
2136
mi
from 91732
Tampa, FL
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
2136
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
1716
mi
from 91732
Vernon Hills, IL
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
1716
mi
from 91732
Vernon Hills, IL
Click here to add this to my saved trials
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated:  11/3/2017
Clinical Research Facility
1793
mi
from 91732
Indianapolis, IN
A Study in Moderate to Severe Rheumatoid Arthritis Participants
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib (LY3009104) in Patients With Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs With Moderately to Severely Active Rheumatoid Arthritis
Status: Enrolling
Updated: 11/3/2017
Clinical Research Facility
1793
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials